How Long Until Immunotherapy Pays Off in Lung Cancer? New Study Puts a Number on It
A reconstructed analysis of ten randomized trials finds that perioperative immunotherapy for resectable lung cancer delivers a 10% reduction in ...
A reconstructed analysis of ten randomized trials finds that perioperative immunotherapy for resectable lung cancer delivers a 10% reduction in ...
A systematic review and meta-analysis of retrospective studies finds insufficient evidence that rituximab-containing frontline therapy independently improves survival in primary ...
A post hoc analysis of the Neo-PLANET trial found that higher spleen metabolic activity on pre-treatment FDG PET scans predicts ...
A new meta-analysis of twenty studies finds that neoadjuvant chemoimmunotherapy is associated with fewer overall recurrences than chemoradiotherapy before surgery ...
A large propensity score-matched study finds that synchronous bilateral breast cancer has distinct biological features but no worse survival than ...
A new meta-analysis of 4,070 patients identifies EGFR L858R, poor performance status, and brain metastases as high-certency predictors of poorer ...
A BMC Cancer study fused a routine blood-based inflammation index with age, smoking history, and AJCC stage to build a ...
A matched single-center comparison of 85 relapsed patients finds no significant overall survival difference between therapeutic donor lymphocyte infusion and ...
A retrospective cohort study from Indonesia's national referral hospital links vimentin expression to dramatically shorter survival in triple-negative breast cancer ...
A Bayesian network meta-analysis of ten randomized trials finds that fruquintinib, regorafenib, and TAS-102 all extend survival in refractory metastatic ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine